| Application no. and date | 07101269.4 (espacenet) (Federated) (European Patent Register), 20010803 | | Patent/reg. no. and date | DK/EP 1775305, 20140917 | | Publication date | 20070418 | | Priority no. and date | GB 0019172, 20000805, GB 0108800, 20010407 | | EP pub. no. and date |
EP 1775305 20070418 | | Effective date | | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | | Applicant ref. no. | 158558 | | Inventor | Biggadike, Keith, GlaxoSmithKline
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
Coote, Steven, John, GlaxoSmithKline
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
Nice, Rosalyn, Kay, c/o GlaxoSmithKline,
9890 Great West Road,
Brentford, Middlesex, TW8 9GS, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/58 (2006.01) , A61P 11/06 (2006.01) , A61P 11/08 (2006.01) , A61P 5/44 (2006.01) , C07J 17/00 (2006.01) , C07J 31/00 (2006.01) | | Title | 6.Alfa.,9.alfa.-difluoro-17.alfa.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alfa.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
